Imagion Biosystems logo

IBX - Imagion Biosystems Share Price

A$0.018 0.0  0.0%

Last Trade - 1:37am

Sector
Healthcare
Size
Micro Cap
Market Cap £3.03m
Enterprise Value £2.45m
Revenue £1.29m
Position in Universe 1526th / 1825
Bullish
Bearish
Unlock IBX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IBX Revenue Unlock IBX Revenue

Net Income

IBX Net Income Unlock IBX Revenue

Normalised EPS

IBX Normalised EPS Unlock IBX Revenue

PE Ratio Range

IBX PE Ratio Range Unlock IBX Revenue

Dividend Yield Range

IBX Dividend Yield Range Unlock IBX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IBX EPS Forecasts Unlock IBX Revenue
Profile Summary

Imagion Biosystems Limited is an Australia-based is engaged in the business of research and development of medical imaging technology through its wholly owned subsidiary, Imagion Biosystems Inc. The Company is focused on the research and development of the MagSense SPMR technology. The Company's technologies include MagSense technology and PrecisionMRX nanoparticles. MagSense technology differentiates benign from malignant tumors since the antibody-conjugated nanoparticles only bind to the targeted tumor cells. MagSense instrument uses sensitive magnetic field sensors to detect the remnant magnetic relaxation of the injected nanoparticles. MagSense nanoparticles are supplied as an injectable solution and formulated to provide delivery to specific types of cancer cells. PrecisionMRX nanoparticles are characterized superparamagnetic nanoparticles. The Company serves a range of applications, including detecting cancer, monitoring therapy and detecting other diseases.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated December 6, 2016
Public Since June 22, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 323,705,324
Free Float (0.0%)
Eligible for
ISAs
SIPPs
Address L 8 555 Bourke St, MELBOURNE, 3000, Australia
Web https://imagionbiosystems.com/
Phone +
Auditors RSM Australia Partners
IBX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to IBX
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.